共 50 条
[1]
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 4-year follow-up of the phase III CheckMate 214 trial
[J].
Albiges, Laurence
;
Tannir, Nizar M.
;
Burotto, Mauricio
;
McDermott, David
;
Plimack, Elizabeth R.
;
Barthelemy, Philippe
;
Porta, Camillo
;
Powles, Thomas
;
Donskov, Frede
;
George, Saby
;
Kollmannsberger, Christian K.
;
Gurney, Howard
;
Grimm, Marc-Oliver
;
Tomita, Yoshihiko
;
Castellano, Daniel
;
Rini, Brian, I
;
Choueiri, Toni K.
;
Saggi, Shruti Shally
;
McHenry, M. Brent
;
Motzer, Robert J.
.
ESMO OPEN,
2020, 5 (06)

Albiges, Laurence
论文数: 0 引用数: 0
h-index: 0
机构:
Gustave Roussy, Dept Canc Med, Villejulf, France Gustave Roussy, Dept Canc Med, Villejulf, France

Tannir, Nizar M.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA Gustave Roussy, Dept Canc Med, Villejulf, France

Burotto, Mauricio
论文数: 0 引用数: 0
h-index: 0
机构:
Bradford Hill Clin Res Ctr, Santiago, Chile Gustave Roussy, Dept Canc Med, Villejulf, France

McDermott, David
论文数: 0 引用数: 0
h-index: 0
机构:
Beth Israel Deaconess Med Ctr, Div Med Oncol, Boston, MA 02215 USA
Dana Farber Harvard Canc Ctr, Boston, MA USA Gustave Roussy, Dept Canc Med, Villejulf, France

Plimack, Elizabeth R.
论文数: 0 引用数: 0
h-index: 0
机构:
Fox Chase Canc Ctr, Dept Hematol & Oncol, 7701 Burholme Ave, Philadelphia, PA 19111 USA Gustave Roussy, Dept Canc Med, Villejulf, France

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Powles, Thomas
论文数: 0 引用数: 0
h-index: 0
机构:
Royal Free NHS Trust, Barts Canc Inst, Dept Urol, London, England
Queen Mary Univ London, London, England Gustave Roussy, Dept Canc Med, Villejulf, France

Donskov, Frede
论文数: 0 引用数: 0
h-index: 0
机构:
Aarhus Univ Hosp, Dept Oncol, Aarhus, Denmark Gustave Roussy, Dept Canc Med, Villejulf, France

George, Saby
论文数: 0 引用数: 0
h-index: 0
机构:
Roswell Park Canc Inst, Dept Med, Buffalo, NY 14263 USA Gustave Roussy, Dept Canc Med, Villejulf, France

Kollmannsberger, Christian K.
论文数: 0 引用数: 0
h-index: 0
机构:
British Columbia Canc Agcy, Dept Med, Vancouver, BC, Canada Gustave Roussy, Dept Canc Med, Villejulf, France

论文数: 引用数:
h-index:
机构:

论文数: 引用数:
h-index:
机构:

Tomita, Yoshihiko
论文数: 0 引用数: 0
h-index: 0
机构:
Niigata Univ, Fac Med, Grad Sch Med & Dent Sci, Niigata, Japan Gustave Roussy, Dept Canc Med, Villejulf, France

Castellano, Daniel
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre, Med Oncol Serv, Madrid, Spain Gustave Roussy, Dept Canc Med, Villejulf, France

Rini, Brian, I
论文数: 0 引用数: 0
h-index: 0
机构:
Vanderbilt Univ, Med Ctr, Div Hematol Oncol, Nashville, TN USA Gustave Roussy, Dept Canc Med, Villejulf, France

Choueiri, Toni K.
论文数: 0 引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA Gustave Roussy, Dept Canc Med, Villejulf, France

Saggi, Shruti Shally
论文数: 0 引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Dept Clin Trials, Princeton, NJ USA Gustave Roussy, Dept Canc Med, Villejulf, France

McHenry, M. Brent
论文数: 0 引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Dept Biostat, Princeton, NJ USA Gustave Roussy, Dept Canc Med, Villejulf, France

Motzer, Robert J.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA Gustave Roussy, Dept Canc Med, Villejulf, France
[2]
Long-Term Overall Survival for Patients with Malignant Pleural Mesothelioma on Pembrolizumab Enrolled in KEYNOTE-028
[J].
Alley, Evan
;
Lopez, Juanita
;
Santoro, Armando
;
Morosky, Anne
;
Saraf, Sanatan
;
Piperdi, Bilal
;
Schellens, Jan H. M.
.
JOURNAL OF THORACIC ONCOLOGY,
2017, 12 (01)
:S294-S294

Alley, Evan
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Penn, Philadelphia, PA 19104 USA Univ Penn, Philadelphia, PA 19104 USA

Lopez, Juanita
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Canc Res, Drug Dev Unit, Sutton, Surrey, England Univ Penn, Philadelphia, PA 19104 USA

Santoro, Armando
论文数: 0 引用数: 0
h-index: 0
机构:
Ist Clin Humanitas, Milan, Italy Univ Penn, Philadelphia, PA 19104 USA

Morosky, Anne
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA Univ Penn, Philadelphia, PA 19104 USA

Saraf, Sanatan
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA Univ Penn, Philadelphia, PA 19104 USA

Piperdi, Bilal
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA Univ Penn, Philadelphia, PA 19104 USA

Schellens, Jan H. M.
论文数: 0 引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Plesmanlaan, Netherlands Univ Penn, Philadelphia, PA 19104 USA
[3]
Clinical safety and activity of pembrolizumab in patients with malignant pleural mesothelioma (KEYNOTE-028): preliminary results from a non-randomised, open-label, phase 1b trial
[J].
Alley, Evan W.
;
Lopez, Juanita
;
Santoro, Armando
;
Morosky, Anne
;
Saraf, Sanatan
;
Piperdi, Bilal
;
van Brummelen, Emilie
.
LANCET ONCOLOGY,
2017, 18 (05)
:623-630

Alley, Evan W.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA

Lopez, Juanita
论文数: 0 引用数: 0
h-index: 0
机构:
Inst Canc Res, Drug Dev Unit, London, England Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA

Santoro, Armando
论文数: 0 引用数: 0
h-index: 0
机构:
Humanitas Univ, Humanitas Canc Ctr, Milan, Italy Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA

Morosky, Anne
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA

Saraf, Sanatan
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA

Piperdi, Bilal
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA

van Brummelen, Emilie
论文数: 0 引用数: 0
h-index: 0
机构:
Netherlands Canc Inst, Amsterdam, Netherlands Univ Penn Hlth Syst, Div Hematol & Oncol, Penn Presbyterian Med Ctr, Philadelphia, PA 19104 USA
[4]
SECOMBIT: The best sequential approach with combo immunotherapy [ipilimumab (I) /nivolumab (N)] and combo target therapy [encorafenib (E)/binimetinib (B)] in patients with BRAF mutated metastatic melanoma: A phase II randomized study
[J].
Ascierto, P. A.
;
Mandala, M.
;
Ferrucci, P. F.
;
Rutkowski, P.
;
Guidoboni, M.
;
Fernandez, A. M. Arance
;
Ferraresi, V.
;
Maiello, E.
;
Guida, M.
;
Del Vecchio, M.
;
Fierro, M. T.
;
Queirolo, P.
;
Lebbe, C.
;
Helgadottir, H.
;
Melero, I.
;
Palmieri, G.
;
Giannarelli, D.
;
Grimaldi, A. M.
;
Dummer, R.
;
Sileni, V. Chiarion
.
ANNALS OF ONCOLOGY,
2021, 32
:S1316-S1317

Ascierto, P. A.
论文数: 0 引用数: 0
h-index: 0

Mandala, M.
论文数: 0 引用数: 0
h-index: 0

Ferrucci, P. F.
论文数: 0 引用数: 0
h-index: 0

Rutkowski, P.
论文数: 0 引用数: 0
h-index: 0

Guidoboni, M.
论文数: 0 引用数: 0
h-index: 0

Fernandez, A. M. Arance
论文数: 0 引用数: 0
h-index: 0

Ferraresi, V.
论文数: 0 引用数: 0
h-index: 0

Maiello, E.
论文数: 0 引用数: 0
h-index: 0

Guida, M.
论文数: 0 引用数: 0
h-index: 0

Del Vecchio, M.
论文数: 0 引用数: 0
h-index: 0

Fierro, M. T.
论文数: 0 引用数: 0
h-index: 0

Queirolo, P.
论文数: 0 引用数: 0
h-index: 0

Lebbe, C.
论文数: 0 引用数: 0
h-index: 0

Helgadottir, H.
论文数: 0 引用数: 0
h-index: 0

Melero, I.
论文数: 0 引用数: 0
h-index: 0

Palmieri, G.
论文数: 0 引用数: 0
h-index: 0

Giannarelli, D.
论文数: 0 引用数: 0
h-index: 0

Grimaldi, A. M.
论文数: 0 引用数: 0
h-index: 0

Dummer, R.
论文数: 0 引用数: 0
h-index: 0

Sileni, V. Chiarion
论文数: 0 引用数: 0
h-index: 0
[5]
DREAMseq (Doublet Randomized Evaluation in Advanced Melanoma Sequencing): A phase III trial-ECOG-ACRIN EA6134
[J].
Atkins, Michael B.
;
Lee, Sandra J.
;
Chmielowski, Bartosz
;
Ribas, Antoni
;
Tarhini, Ahmad A.
;
Truong, Thach-Giao
;
Davar, Diwakar
;
O'Rourke, Mark Allen
;
Curti, Brendan D.
;
Brell, Joanna M.
;
Kendra, Kari Lynn
;
Wolchok, Jedd D.
;
Kirkwood, John M.
;
Ikeguchi, Alexandra
.
JOURNAL OF CLINICAL ONCOLOGY,
2021, 39 (36)

Atkins, Michael B.
论文数: 0 引用数: 0
h-index: 0
机构:
Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Lee, Sandra J.
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Chmielowski, Bartosz
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Ribas, Antoni
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Tarhini, Ahmad A.
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Truong, Thach-Giao
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Davar, Diwakar
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

O'Rourke, Mark Allen
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Curti, Brendan D.
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Brell, Joanna M.
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Kendra, Kari Lynn
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Wolchok, Jedd D.
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Kirkwood, John M.
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA

Ikeguchi, Alexandra
论文数: 0 引用数: 0
h-index: 0
机构: Georgetown Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA
[6]
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
[J].
Baas, Paul
;
Scherpereel, Arnaud
;
Nowak, Anna K.
;
Fujimoto, Nobukazu
;
Peters, Solange
;
Tsao, Anne S.
;
Mansfield, Aaron S.
;
Popat, Sanjay
;
Jahan, Thierry
;
Antonia, Scott
;
Oulkhouir, Youssef
;
Bautista, Yolanda
;
Cornelissen, Robin
;
Greillier, Laurent
;
Grossi, Francesco
;
Kowalski, Dariusz
;
Rodriguez-Cid, Jeronimo
;
Aanur, Praveen
;
Oukessou, Abderrahim
;
Baudelet, Christine
;
Zalcman, Gerard
.
LANCET,
2021, 397 (10272)
:375-386

论文数: 引用数:
h-index:
机构:

Scherpereel, Arnaud
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Lille, CHU Lille, INSERM U1189, Pulm & Thorac Oncol,OncoThAI, Lille, France Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Nowak, Anna K.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Western Australia, Sch Med, Perth, WA, Australia
Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Fujimoto, Nobukazu
论文数: 0 引用数: 0
h-index: 0
机构:
Okayama Rosai Hosp, Okayama, Japan Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Peters, Solange
论文数: 0 引用数: 0
h-index: 0
机构:
Lausanne Univ Hosp, Lausanne, Switzerland Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Tsao, Anne S.
论文数: 0 引用数: 0
h-index: 0
机构:
MD Anderson Canc Ctr, Houston, TX USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Mansfield, Aaron S.
论文数: 0 引用数: 0
h-index: 0
机构:
Mayo Clin, Rochester, MN USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Popat, Sanjay
论文数: 0 引用数: 0
h-index: 0
机构:
Royal Marsden Hosp, London, England
Inst Canc Res, London, England Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Jahan, Thierry
论文数: 0 引用数: 0
h-index: 0
机构:
UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Antonia, Scott
论文数: 0 引用数: 0
h-index: 0
机构:
H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Oulkhouir, Youssef
论文数: 0 引用数: 0
h-index: 0
机构:
Hop Cote Nacre CHU Caen, Caen, France Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Bautista, Yolanda
论文数: 0 引用数: 0
h-index: 0
机构:
Ctr Med Nacl Siglo XXI, Mexico City, DF, Mexico Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Cornelissen, Robin
论文数: 0 引用数: 0
h-index: 0
机构:
Erasmus MC Canc Inst, Rotterdam, Netherlands Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Greillier, Laurent
论文数: 0 引用数: 0
h-index: 0
机构:
Aix Marseille Univ, Multidisciplinary Oncol & Therapeut Innovat Dept, Hop Nord, APHM,INSERM,CNRS,CRCM, Marseille, France Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Grossi, Francesco
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Kowalski, Dariusz
论文数: 0 引用数: 0
h-index: 0
机构:
Maria Sklodowska Curie Natl Res Inst Oncol, Dept Lung Canc & Chest Tumours, Warsaw, Poland Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Rodriguez-Cid, Jeronimo
论文数: 0 引用数: 0
h-index: 0
机构:
Med Sur Inst Nacl Enfermedades Resp, Ctr Oncol, Mexico City, DF, Mexico Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Aanur, Praveen
论文数: 0 引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Bristol, NJ USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Oukessou, Abderrahim
论文数: 0 引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Bristol, NJ USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Baudelet, Christine
论文数: 0 引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Bristol, NJ USA Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands

Zalcman, Gerard
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Paris, Bichat Claude Bernard Univ Hosp, AP HP, Paris, France Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands
[7]
First-line pembrolizumab in cisplatin-ineligible patients with locally advanced and unresectable or metastatic urothelial cancer (KEYNOTE-052): a multicentre, single-arm, phase 2 study
[J].
Balar, Arjun V.
;
Castellano, Daniel
;
O'Donnell, Peter H.
;
Grivas, Petros
;
Vuky, Jacqueline
;
Powles, Thomas
;
Plimack, Elizabeth R.
;
Hahn, Noah M.
;
de Wit, Ronald
;
Pang, Lei
;
Savage, Mary J.
;
Perini, Rodolfo F.
;
Keefe, Stephen M.
;
Bajorin, Dean
;
Bellmunt, Joaquim
.
LANCET ONCOLOGY,
2017, 18 (11)
:1483-1492

Balar, Arjun V.
论文数: 0 引用数: 0
h-index: 0
机构:
NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Castellano, Daniel
论文数: 0 引用数: 0
h-index: 0
机构:
Hosp Univ 12 Octubre CiberOnc, Madrid, Spain NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

O'Donnell, Peter H.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Chicago, Med Ctr, Chicago, IL 60637 USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Grivas, Petros
论文数: 0 引用数: 0
h-index: 0
机构:
Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Vuky, Jacqueline
论文数: 0 引用数: 0
h-index: 0
机构:
Oregon Hlth & Sci Univ, Portland, OR 97201 USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Powles, Thomas
论文数: 0 引用数: 0
h-index: 0
机构:
Queen Mary Univ London, Barts Canc Inst, London, England NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Plimack, Elizabeth R.
论文数: 0 引用数: 0
h-index: 0
机构:
Fox Chase Canc Ctr, Philadelphia, PA 19111 USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Hahn, Noah M.
论文数: 0 引用数: 0
h-index: 0
机构:
Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

de Wit, Ronald
论文数: 0 引用数: 0
h-index: 0
机构:
Erasmus MC Canc Inst, Rotterdam, Netherlands NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Pang, Lei
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Savage, Mary J.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Perini, Rodolfo F.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Keefe, Stephen M.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck & Co Inc, Kenilworth, NJ USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

Bajorin, Dean
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA NYU, Langone Med Ctr, Perlmutter Canc Ctr, New York, NY 10016 USA

论文数: 引用数:
h-index:
机构:
[8]
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
[J].
Bellmunt, J.
;
de Wit, R.
;
Vaughn, D. J.
;
Fradet, Y.
;
Lee, J. -L.
;
Fong, L.
;
Vogelzang, N. J.
;
Climent, M. A.
;
Petrylak, D. P.
;
Choueiri, T. K.
;
Necchi, A.
;
Gerritsen, W.
;
Gurney, H.
;
Quinn, D. I.
;
Culine, S.
;
Sternberg, C. N.
;
Mai, Y.
;
Poehlein, C. H.
;
Perini, R. F.
;
Bajorin, D. F.
.
NEW ENGLAND JOURNAL OF MEDICINE,
2017, 376 (11)
:1015-1026

论文数: 引用数:
h-index:
机构:

de Wit, R.
论文数: 0 引用数: 0
h-index: 0
机构:
Erasmus MC Canc Inst, Rotterdam, Netherlands Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Vaughn, D. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Fradet, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Laval, Ctr Hosp Univ Quebec, Quebec City, PQ, Canada Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Lee, J. -L.
论文数: 0 引用数: 0
h-index: 0
机构:
Asan Med Ctr, Seoul, South Korea
Univ Ulsan, Coll Med, Seoul, South Korea Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Fong, L.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Calif San Francisco, San Francisco, CA 94143 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Vogelzang, N. J.
论文数: 0 引用数: 0
h-index: 0
机构:
Comprehens Canc Ctr Nevada, Las Vegas, NV USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Climent, M. A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn Inst Valenciano Oncol, Valencia, Spain Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Petrylak, D. P.
论文数: 0 引用数: 0
h-index: 0
机构:
Yale Univ, Smilow Canc Hosp, New Haven, CT USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Choueiri, T. K.
论文数: 0 引用数: 0
h-index: 0
机构:
Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Necchi, A.
论文数: 0 引用数: 0
h-index: 0
机构:
Fdn IRCCS Ist Nazl Tumori, Milan, Italy Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Gerritsen, W.
论文数: 0 引用数: 0
h-index: 0
机构:
Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

论文数: 引用数:
h-index:
机构:

Quinn, D. I.
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Southern Calif, Norris Comprehens Canc Ctr & Hosp, Los Angeles, CA USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Culine, S.
论文数: 0 引用数: 0
h-index: 0
机构:
Hop St Louis, Paris, France Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Sternberg, C. N.
论文数: 0 引用数: 0
h-index: 0
机构:
San Camillo Hosp, Rome, Italy
Forlanini Hosp, Rome, Italy Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Mai, Y.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Poehlein, C. H.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Perini, R. F.
论文数: 0 引用数: 0
h-index: 0
机构:
Merck, Kenilworth, NJ USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA

Bajorin, D. F.
论文数: 0 引用数: 0
h-index: 0
机构:
Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA Dana Farber Canc Inst, 450 Brookline Ave,Dana Bldg 1230, Boston, MA 02215 USA
[9]
Borghaei H, 2021, J CLIN ONCOL, V39, P723, DOI 10.1200/JCO.20.01605
[10]
Survival and prognosis of individuals receiving programmed cell death 1 inhibitor with and without immunologic cutaneous adverse events
[J].
Chan, Linda
;
Hwang, Shelley J. E.
;
Byth, Karen
;
Kyaw, Merribel
;
Carlino, Matteo S.
;
Chou, Shaun
;
Fernandez-Penas, Pablo
.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY,
2020, 82 (02)
:311-316

Chan, Linda
论文数: 0 引用数: 0
h-index: 0
机构:
Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia

论文数: 引用数:
h-index:
机构:

Byth, Karen
论文数: 0 引用数: 0
h-index: 0
机构:
Westmead Hosp, Western Sydney Local Hlth Dist, Res & Educ Network, Sydney, NSW, Australia
Univ Sydney, Sydney Med Sch, NHMRC Clin Trials Ctr, Sydney, NSW, Australia Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia

Kyaw, Merribel
论文数: 0 引用数: 0
h-index: 0
机构:
Westmead Hosp, Dept Radiol, Sydney, NSW, Australia Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia

Carlino, Matteo S.
论文数: 0 引用数: 0
h-index: 0
机构:
Westmead & Blacktown Hosp, Crown Princess Mary Canc Ctr, Sydney, NSW, Australia
Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia

Chou, Shaun
论文数: 0 引用数: 0
h-index: 0
机构:
Westmead Hosp, Tissue Pathol & Diagnost Oncol, Sydney, NSW, Australia Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia

Fernandez-Penas, Pablo
论文数: 0 引用数: 0
h-index: 0
机构:
Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia
Univ Sydney, Sydney Med Sch, Westmead, NSW, Australia Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia